{
  "basic_data": [
    {
      "frozen": "True",
      "cell_type": "hiPSC",
      "cell_line_alt_name": "iPSC-7247-G5",
      "hpscreg_name": "HPI003-A"
    }
  ],
  "generator": [
    {
      "group": "Harry Perkins Institute of Medical Research"
    }
  ],
  "contact": [
    {
      "name_initials": "S",
      "group": "Harry Perkins Institute of Medical Research",
      "e_mail": "joshua.clayton@perkins.org.au",
      "last_name": "Clayton",
      "first_name": "Joshua"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2022.102829",
      "title": "Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p. Ala172Glu) variant in the ACTA1 gene",
      "journal": "Stem Cell Research",
      "last_author": "Rhonda L. Taylor",
      "first_author": "Joshua S. Clayton",
      "year": "2022.0",
      "pmid": "35750611"
    }
  ],
  "donor": [
    {
      "sex": "Female",
      "age": "A1_4",
      "disease_description": "Intermediate nemaline myopathy with heterozygous dominant ACTA1 c.515C > A (p.Ala172Glu) variant",
      "disease_name": "Nemaline myopathy 3; NEM3"
    }
  ],
  "genomic_modifications": [
    {
      "cytoband": "1q42.13",
      "genotype": "NM_001100. c.515C > A (p.Ala172Glu)",
      "mutation_type": "Variant",
      "loci_name": "ACTA1",
      "description": "Heterozygous dominant ACTA1 c.515C > A (p.Ala172Glu) variant"
    }
  ],
  "differentiation_results": [
    {
      "marker_list": "OTX2; PAX6",
      "method_used": "qPCR; immunocytochemistry",
      "show_potency": "True",
      "cell_type": "Ectoderm",
      "description": "in vitro directed differentiation"
    },
    {
      "marker_list": "TBXT; BMP4",
      "method_used": "qPCR; immunocytochemistry",
      "show_potency": "True",
      "cell_type": "Mesoderm",
      "description": "in vitro directed differentiation"
    },
    {
      "marker_list": "SOX17; GATA4",
      "method_used": "qPCR; immunocytochemistry",
      "show_potency": "True",
      "cell_type": "Endoderm",
      "description": "in vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "karyotype": "46, XX",
      "karyotype_method": "G-banding",
      "summary": "Normal female karyotype (46, XX) confirmed by G-banding (n = 15 chromosomal spreads).",
      "passage_number": "10"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "EBV-immortalized lymphoblastoid cell line (LCL)",
      "non_int_vector": "Sendai virus",
      "derivation_year": "2021",
      "non_int_vector_name": "CytoTune-iPS 2.0 Sendai reprogramming kit",
      "i_source_cell_origin_term": "blood"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "Est IV DC 2012-1693",
      "institutional_HREC": "Comit\u00e9 de Protection des Personnes"
    },
    {
      "ethics_number": "RA/4/20/1008",
      "institutional_HREC": "University of Western Australia Human Research Ethics Committee"
    },
    {
      "ethics_number": "2018-3156",
      "institutional_HREC": "Genethon"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "Enzymatically"
    }
  ]
}